search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
LONGEVITY 25 Instead, it offers the opportunity to reach


further than before. The longevity movement is one of the major disruptive developments of our lifetimes. It introduces many new targets and mechanisms of action for actives, but treatments are still in the early innings. Hybrid approaches currently offer a complete


and consumer frictionless approach to advancing the personal care industry; ester technologies and combined complexes are two prime examples. They build on the rich foundation of clinical data while leveraging the many new mechanisms being elucidated today in an economically efficient manner.


This is one window into an exciting future of


many possibilities; there will be more to come. As we step into the chaos of uncertainty and from its wild machinations craft new modes of order, one final note rings true evermore: there is boundless beauty in destruction and creation. Two sides of the same coin.


References 1. Haydont V, Bernard BA, Fortunel NO. Age- related evolutions of the dermis: Clinical signs, fibroblast and extracellular matrix dynamics. Mechanisms of Ageing and Development. 2019;177:150–156.


2. Pilkington SM, Bulfone-Paus S, Griffiths CEM, Watson REB. Inflammaging and the Skin. Journal of Investigative Dermatology. 2021;141(4):1087–1095.


3. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243–278.


4. Schoenmaker M, De Craen AJM, De Meijer PHEM, Beekman M, Blauw GJ, Slagboom PE, Westendorp RGJ. Evidence of genetic enrichment for exceptional survival using a family approach: The Leiden Longevity Study. European Journal of Human Genetics.


2006;14(1):79–84.


5. Waaijer MEC, Parish WE, Strongitharm BH, Van Heemst D, Slagboom PE, De Craen AJM, Sedivy JM, Westendorp RGJ, Gunn DA, Maier AB. The number of p16INK4a positive cells in human skin reflects biological age. Aging Cell. 2012;11(4):722–725.


6. Waaijer MEC, Gunn DA, Adams PD, Pawlikowski JS, Griffiths CEM, Van Heemst D, Slagboom PE, Westendorp RGJ, Maier AB. P16INK4a positive cells in human skin are indicative of local elastic fiber morphology, facial wrinkling, and perceived age. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 2016;71(8):1022–1028.


7. Massudi H, Grant R, Braidy N, Guest J, Farnsworth B, Guillemin GJ. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS ONE. 2012;7(7):e42357


PCM


8. Victorelli S, Lagnado A, Halim J, Moore W, Talbot D, Barrett K, Chapman J, Birch J, Ogrodnik M, Meves A, Pawlikowski JS, Jurk D, Adams PD, Van Heemst D, Beekman M, Slagboom PE, Gunn DA, Passos JF. Senescent human melanocytes drive skin ageing via paracrine telomere dysfunction. The EMBO Journal. 2019;38(23):e101982


9. Weinmüllner R, Zbiral B, Becirovic A, Stelzer EM, Nagelreiter F, Schosserer M, Lämmermann I, Liendl L, Lang M, Terlecki-Zaniewicz L, Andriotis O, Mildner M, Golabi B, Waidhofer- Söllner P, Schedle K, Emsenhuber G, Thurner PJ, Tschachler E, Gruber F, Grillari J. Organotypic human skin culture models constructed with senescent fibroblasts show hallmarks of skin aging. NPJ Aging and Mechanisms of Disease. 2020;6(1):4


10. Xie N, Zhang L, Gao W, Huang C, Huber PE, Zhou X, Li C, Shen G, Zou B. NAD+ metabolism: Pathophysiologic mechanisms and therapeutic


potential. Signal Transduction and Targeted Therapy. 2020;5(1):227


11. Oyama T, Yamamoto T, Kameda T, Kamiya T, Abe H, Abe T, Tanuma S. Supplementation of nicotinic acid and its derivatives up-regulates cellular NAD+ level rather than nicotinamide derivatives in cultured normal human epidermal keratinocytes. Life. 2024;14(3):413


12. McReynolds MR, Chellappa K, Baur JA. Age-related NAD+ decline. Experimental Gerontology. 2020;134:110888


13. Morrow JD, Awad JA, Oates JA, Roberts LJ. Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. Journal of Investigative Dermatology. 1992;98(5):812–815


14. Escande C, Nin V, Price NL, Capellini V, Gomes AP, Barbosa MT, O’Neil L, White TA, Sinclair DA, Chini EN. Flavonoid apigenin is an inhibitor of the NAD+ase CD38. Diabetes. 2013;62(4):1084– 1093


15. Chen R, Zhang X, Zhu X, Wang C, Xu W. Myricetin alleviated hydrogen peroxide- induced cellular senescence of nucleus pulposus cells through regulating SERPINE1. Journal of Orthopaedic Surgery and Research. 2023;18(1):143


16. Kang S, Park J, Cheng Z, Ye S, Jun S-H, Kang N-G. Novel approach to skin anti-aging: Boosting pharmacological effects of exogenous nicotinamide adenine dinucleotide ( NAD+) by synergistic inhibition of CD38 expression. Cells. 2024;13(21):1799


17. Lephart ED, Sommerfeldt JM, Andrus MB. Resveratrol: Influences on gene expression in human skin. Journal of Functional Foods. 2014;10:377–384


18. Na J-I, Shin J-W, Choi H-R, Kwon S-H, Park K-C. Resveratrol as a multifunctional topical hypopigmenting agent. International Journal of Molecular Sciences. 2019;20(4):956


www.personalcaremagazine.com


May 2026 PERSONAL CARE MAGAZINE


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100